Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety ...

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced progress in its Phase 1 clinical trial for OCU200, a novel biologic ...

This week Bobbi Conner talks with Dr. Peter Tang about potential diabetes related vision changes. Dr. Tang is an ...

As someone with relatively normal under-eyes, I’ve never had much use for eye creams, even though they’ve always been touted as a must-have for anyone who was serious about their multistep ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) ...

15, 2025 — Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes researchers have found. That suggests doctors may be able to use data from the ...

The authors commented that the patient’s "age, relative acute onset, and lack of medical history make this an atypical ...

Minimally invasive glaucoma surgeries offer an alternative to glaucoma drops, which, in some cases, do not adequately lower IOP and show poor compliance.

The FDA approved an expanded label for Iluvien, which is now indicated for the treatment of chronic noninfectious uveitis ...

US FDA approves expanded label for ANI Pharma’s Iluvien to treat chronic non-infectious uveitis affecting the posterior segment of the eye: Baudette, Minnesota Monday, March 17, ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME)ANI plans to begin marketing ILU ...